Full-Time

Head – General Medicines

Genmed, Commercial Operations Finance

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Global healthcare provider of medicines and vaccines

Biotechnology
Healthcare

Expert

Cambridge, MA, USA + 1 more

More locations: Bridgewater Township, NJ, USA

Onsite presence required.

Category
Corporate Finance
Financial Planning and Analysis (FP&A)
Risk Management
Finance & Banking

You match the following Sanofi's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Minimum 10+ years relevant Accounting/Finance/Industry experience
  • B.A/B.S. Accounting/Finance
  • CPA and/or MBA preferred
  • Experience in business partnering required
  • Strong understanding and experience with the US pharmaceutical industry and market is preferred
  • Knowledge of US Gross to Net and direct management experience of commercial P&L is strongly desired
  • Ability to influence, drive and manage innovation
  • Exhibits political and interpersonal savvy
  • Sees the 'big picture' and reads emerging trends and patterns very effectively
  • Demonstrates strategic agility
  • Able to effectively manage competing priorities with consideration to the highest level of business impact and maintain control over multiple priorities simultaneously
  • Builds strong and effective teams, encourages others to develop new or higher levels of skills and knowledge
  • Possesses a strong sense of urgency
  • Generally remains calm and collected regardless of pressure experiences
  • Consistently demonstrates an entrepreneurial spirit and fosters a culture of innovation
  • Challenges the status quo and applies a thoughtful risk taking approach.
Responsibilities
  • Lead financial planning, forecasting, and budgeting to align with corporate goals
  • Drive growth to achieve top line sales targets and deliver BOI via efficient management of pricing strategies as well as diligent resource allocation
  • Coordinate the development of US business unit sales and operating profit forecasts for all required budget processes
  • In conjunction with Marketing management, develop all required sales forecasts and in conjunction with all areas of Commercial Operations management develop operating expense budgets
  • Coordinate review by Sr. business unit management and ensure all required corporate submissions are completed in accordance with established timelines and guidelines
  • Play a key role in the development of business unit budget and operating plan presentations for Sanofi GenMed and Sanofi Group executive review
  • Contribute to forecasting transformation leveraging monthly forecast process and AI
  • Play a key role in the development, implementation, administration and assessment of Sanofi GenMed pricing and contracting policies, strategies and tactics
  • Ensure accurate and timely financial reporting in compliance with local regulations and corporate policies
  • Complete all month-end closing accounting activities and reporting requirements in compliance with all applicable accounting standards, statutory requirements and corporate reporting requirements and timelines
  • Ensure compliance with all corporate policies and procedures for the approval, commitment and incurrence of operating expenses
  • Provide routine and ad hoc reports and analyses to and conduct meetings with Sr. management to update them on the status of their budgets
  • Conduct on-going review of budgets to identify, assess & investigate budget variances, provide recommendations to address expected variances and monitoring business initiatives and priorities and provide recommendations on budget reallocations and changes to ensure business needs are met within approved budgeted spending levels
  • Monitoring and evaluate the adequacy of related balance sheet reserve accounts
  • Collaborate with senior leadership to drive strategic decision making and operational efficiency
  • Analyze key financial metrics and business performance indicators, act as a trusted advisor to senior management and franchise/function heads to identify and mitigate financial risks
  • Identify, assess and mitigate financial risks including compliance and legal risks
  • Accelerate implementation and adoption of financial tools and systems (Plai, PowerBI, AI forecasting)
  • Work closely with US and Global Treasury team to manage cash flow and working capital
  • Responsible for inbound cash flow forecasting and achievement of corporate cash flow and DSO objectives
  • In partnership with Treasury and GenMed Pricing Committee, approve all payment terms
  • Ensure adherence to tax, audit, government legislation and specific country financial regulations
  • Lead, mentor and develop the US GenMed team, fostering a high-performance, collaborative culture
Desired Qualifications
  • Strong understanding and experience with the US pharmaceutical industry and market is preferred
  • CPA and/or MBA preferred

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse pipeline of products. The company's goal is to enhance health outcomes and improve the quality of life for people globally.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for tolebrutinib boosts Sanofi's neurology leadership.
  • Sanofi's Muse AI tool accelerates patient recruitment, reducing clinical trial timelines.
  • Investment in Zucara Therapeutics strengthens Sanofi's diabetes portfolio with innovative treatments.

What critics are saying

  • Regulatory delays in Japan and China for Sarclisa could impact revenue projections.
  • Liver enzyme elevations in tolebrutinib trials may lead to regulatory scrutiny.
  • Reliance on strategic partnerships poses risks if expected results are not achieved.

What makes Sanofi unique

  • Sanofi's Sarclisa is the first anti-CD38 therapy combined with VRd in the EU.
  • The Care4Rare program focuses on lysosomal storage diseases, offering unique patient solutions.
  • Sanofi's MyWay app enhances patient engagement and medication adherence through digital health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Parental Leave